These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35288618)

  • 1. Cell cycle arrest is an important mechanism of action of compound Kushen injection in the prevention of colorectal cancer.
    Sun J; Li M; Lin T; Wang D; Chen J; Zhang Y; Mu Q; Su H; Wu N; Liu A; Yu Y; Liu Y; Wang S; Yu X; Guo J; Yu W
    Sci Rep; 2022 Mar; 12(1):4384. PubMed ID: 35288618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
    Wu X; Lu Y; Qin X
    J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
    He R; Ou S; Chen S; Ding S
    Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
    Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
    J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herba Patriniae and its component Isovitexin show anti-colorectal cancer effects by inducing apoptosis and cell-cycle arrest via p53 activation.
    Li J; Shang L; Zhou F; Wang S; Liu N; Zhou M; Lin Q; Zhang M; Cai Y; Chen G; Yang S
    Biomed Pharmacother; 2023 Dec; 168():115690. PubMed ID: 37939611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics.
    Qu Z; Cui J; Harata-Lee Y; Aung TN; Feng Q; Raison JM; Kortschak RD; Adelson DL
    Oncotarget; 2016 Oct; 7(40):66003-66019. PubMed ID: 27602759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
    Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
    Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
    Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
    BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine.
    Liang S; Li Y; Zhang X; Guo Y; Pan S
    Anticancer Agents Med Chem; 2021; 21(15):2012-2022. PubMed ID: 33573576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.
    Gao L; Wang KX; Zhou YZ; Fang JS; Qin XM; Du GH
    Sci Rep; 2018 Jan; 8(1):624. PubMed ID: 29330507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
    Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
    BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle.
    Aung TN; Nourmohammadi S; Qu Z; Harata-Lee Y; Cui J; Shen HY; Yool AJ; Pukala T; Du H; Kortschak RD; Wei W; Adelson DL
    Sci Rep; 2019 Oct; 9(1):14200. PubMed ID: 31578346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms.
    Cui J; Qu Z; Harata-Lee Y; Shen H; Aung TN; Wang W; Kortschak RD; Adelson DL
    PLoS One; 2020; 15(7):e0236395. PubMed ID: 32730293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation.
    Wu C; Huang ZH; Meng ZQ; Fan XT; Lu S; Tan YY; You LM; Huang JQ; Stalin A; Ye PZ; Wu ZS; Zhang JY; Liu XK; Zhou W; Zhang XM; Wu JR
    Chin Med; 2021 Nov; 16(1):121. PubMed ID: 34809653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the pharmacological mechanism of compound kushen injection in the treatment of breast cancer using
    Ye Y; Zhang B; Liang Q; Wang D; Bai F; Li Y; Wei L; Li L; Huang H; Tang Y
    Front Oncol; 2022; 12():946758. PubMed ID: 36016606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Advanced Systems Pharmacology Strategy Reveals
    Zhou W; Wu C; Zhao C; Huang Z; Lu S; Fan X; Tan Y; Stalin A; You R; Liu X; Zhang J; Wu Z; Wu J
    Front Cell Dev Biol; 2021; 9():742421. PubMed ID: 34646828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway.
    Xu W; Lin H; Zhang Y; Chen X; Hua B; Hou W; Qi X; Pei Y; Zhu X; Zhao Z; Yang L
    J Exp Clin Cancer Res; 2011 Oct; 30(1):103. PubMed ID: 22032476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
    Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
    J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-tumor and analgesic activity evaluation and mechanism of Compound Kushen Injection].
    Fan QQ; She GM; Wei J; Li ZQ; Chen ML; Dong Y; Yu AX; Li JW; Qin WJ; Wang W; Lin RC; Zhao CJ; You RL
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2712-2720. PubMed ID: 35718491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.